Sir,
The report of Dr Adebajo and colleagues' includes a further report of a patient with facial hemiatrophy and localized scleroderma, an association which has been previously reported2'3 and which invites speculation as to a possible shared pathogenetic mechanism. Such a mechanism may also be applicable to certain patients with 'idiopathic' Parry-Romberg hemifacial atrophy (PRHFA), the aetiology of which has in the past prompted much speculation.
Reporting on a boy with mild hemifacial atrophy, localized leg and trunk scleroderma, and positive antinuclear antibodies, Lewkonia 
